Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000476

Drug Information
NameThioridazine    
SynonymsMellaril (*Hydrochloride*); KBio1_000066; Melleril; Ridazine; Spectrum_001066; Thioridazin; Tioridazina [INN-Spanish]; Spectrum4_000356; Melleril (liquid); 50-52-2; cMAP_000015; DivK1c_000066; BPBio1_000325; Prestwick0_000078; 57129-06-3; Mallorol; Lopac0_001252; Mellerette; KBio2_002308; BPBio1_001175; NCGC00089809-03; Thioridazine, prolongatum; 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-; D00373; Sonapax; Prestwick1_000078; Thioridazine Hcl Intensol; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine; Stalleril; SPBio_002216; SPBio_001483; KBio2_004876; AC1L1KDN; NINDS_000066; Thioxidazine; KBioSS_001546; TP-21; 10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-; Orsanil; Melleryl; CHEBI:9566; Mellarit; L001321; Spectrum5_001062; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine; BSPBio_002030; Thioridazine Hcl; KBio3_002788; Thoridazine hydrochloride; KBio2_006682; Meleril; Thioridazinum [INN-Latin]; CHEMBL479; HMS2090J04; UNII-N3D6TG58NI; KBio2_004114; NCGC00089809-02; Tioridazina; Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-; Mellaril-S (TN); Prestwick2_000078; Metlaril; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; KBio3_001530; Mellaril; thioridazine; Tioridazin; Thioridazine (USP/INN); Thioridazine prolongatum; DB00679; KBioSS_002310; EINECS 200-044-2; Phenothiazine, 10-((1-methyl-2-piperidyl)ethyl)-2-(methylthio)-; Malloryl; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; Melleretten; C21H26N2S2; dl-Thioridazine; HSDB 3189; LS-105605; Mellerets; IDI1_000066; KBio2_007444; Novoridazine; (+-)-Thioridazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine; BSPBio_000295; 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine; Thioridazine [USAN:INN:BAN]; Thioridazinum; CID5452; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine; Spectrum3_000585; AI3-51923; AB00053553; Prestwick3_000078; Aldazine; Biomol-NT_000017; Mellaril-S; KBioGR_000791; Spectrum2_001332; KBioGR_002308; KBio2_001546; NCGC00016059-10    
Trade NameMellaril; Novoridazine; Thioril    
CompanyNorvatis Phamaceuticals Corporation    
IndicationSchizophreniaApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntipsychotic Agents    
CAS NumberCAS 50-52-2
FormularC21H26N2S2    
PubChem Compound IDCID 5452.    
PubChem Substance IDSID 148555.    
ChEBI9566;    
SuperDrug ATC IDN05AC02;    
SuperDrug CAS ID000050522;    
TargetAlpha adrenergic receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 088001 To Reference
Ref 2Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat. Eur Neuropsychopharmacol. 2005 Mar;15(2):231-4. To Reference
Ref 3Models of drug treatment in the attention deficit disorder with hyperactivity. Rev Neurol. 2002 Feb;34 Suppl 1:S98-S106. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543